Funding for this research was provided by:
Israel Science Foundation (3073/19)
Article History
Received: 11 January 2022
Accepted: 31 August 2022
First Online: 19 September 2022
Change Date: 12 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13073-022-01122-x
Declarations
:
: We have only utilized previously published publicly available data. Our research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: I.T. is an advisory board member of Immunitas Therapeutics. M.L.S. is an equity holder, scientific co-founder, and advisory board member of Immunitas Therapeutics. The authors declare that such activities have no relationship to the present study. The remaining authors declare that they have no competing interests.